LDS/Medical Tests/ATP-binding cassette transporter A1 (ABCA1) Genotyping

ATP-binding cassette transporter A1 (ABCA1) Genotyping

ATP-binding cassette transporter A1 (ABCA1) is a protein belonging to the superfamily of ATP-binding cassette proteins and sub-family ABC1 also known asP-glycoprotein (P-gp) . The protein is coded by the ABCA1 gene located 9q31.1. This membrane protein is responsible for transporting unesterified cholesterol and phospholipids out of cells which combine with apolipoprotein A-1 to form high-density lipoprotein (HDL).

Mutations in the ABCA1 gene may result in impaired formation and function of ABCA1 protein, In Familial HDL deficiency is an autosomal dominant disorder due to mutation in one copy of the gene and results in reduced levels of ABCA1 and very low serum levels of HDL. People with this disorder are susceptible to the onset heart diseases before age 50.

Tangier disease is a co-dominant disorder due to loss-of-function mutations in both ABCA1 genes and causes the accumulation of cholesterol and phospholipids in cells throughout the body, particularly the reticuloendothelial system. Clinically, Tangier disease is characterized by enlarged yellowish-orange tonsils, hepatosplenomegaly and peripheral neuropathy. Less commonly patients with Tangier disease develop premature coronary atherosclerosis in the 6th or seveth decades of life.

The role of the ABCB1 gene in drug disposition in humans has been shown in clinical studies investigating the impact of inhibitors/inducers onP-gp function, and in studies documenting the pharmacogenetics of P-gp substrates in carriers of the 3435C>T variant. P-gp recognizes and effluxes a multitude of structurally and biochemically unrelated substrates. The ABCB1 3435 T allele was first reported to be associated with altered P-gp function and increased plasma levels of P-gp substrate digoxin relative to the ABCB1 3435 C allele. Subsequent pharmacogenetic studies on this polymorphism involving a variety of P-gp substrates have shown mixed results. In patients who are taking standard doses of antiemetic drugs, specifically ondansetron and granisetron, several studies have consistently shown increased drug exposure and lower risk of vomiting associated with the ABCB1 3435 T/T genotype. Patients with the 3435 C/C and C/T genotypes are at a high risk of therapeutic failurewhen treated with standard doses of ondansetron or granisetron.

  • Useful in the diagnosis of Tangier disease
  • Useful in the diagnosis of Familial HDL deficiency
  • Useful in pharmacogenetics of antiemetic drugs
A positive result indicates the presence of mutations or pathogenic variants in the ABCA1 gene. A negative result indicates the absence of mutations or pathogenic variants in the ABCA1 gene. Despite the negative test, the person might be susceptible to cardiovascular disorders due to other factors including lifestyle and heredity.

The reference range for ABCB1 rs1045642 (3435C>T) is C/C. This is consistent with high transporter expression

Real-time Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Deletion/duplication analysis, and sequencing of the entire coding region.

Whole blood, Lavender-top (EDTA) tube, buccal swab, saliva.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unstable
Serum HDL, LDL, triglycerides, total cholesterol, hs-CRP, APOA1 gene mutation analysis.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Transl Res. 2007: 4;149(4):205-10 [PMID: 17383594]
  • Clin Pharmacol Ther. 2005 Dec;78(6):619-26. [PMID: 16338277]
  • Jpn J Clin Oncol. 2011 Oct;41(10):1168-76. [PMID: 21840870]
  • Atherosclerosis. 2005 Dec;183(2):199-212. [PMID: 15935359]
  • J Clin Invest. 2004 Nov;114(9):1343-53. [PMID: 15520867]
  • Hum Genet. 2003: 7;113(2):106-17 [PMID: 12709788]
  • Tangier Disease. 2019 Nov 21. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022.